<p>Decoy Therapeutics 在加速执行中建立了势头，进入了一个高度催化的阶段，清晰地定义了其抗病毒管线的临床开发路径 | DCOY 股票新闻</p>

DCOY

<p>Decoy Therapeutics 在加速执行中积累势头，进入一个高度催化的阶段，明确了其抗病毒管线的临床开发路径 | DCOY 股票新闻</p>

<p>Decoy Therapeutics Builds Momentum with Accelerating Execution, Entering a Highly Catalytic Phase with a Clearly Defined Path to Clinical Development of its Antiviral Pipeline | DCOY Stock News</p>
<div class="lb-trans"><p>Decoy Therapeutics 在加速执行中建立了势头，进入了一个高度催化的阶段，清晰地定义了其抗病毒管线的临床开发路径 | DCOY 股票新闻</p>
</div>

Decoy Therapeutics Builds Momentum with Accelerating Execution, Entering a Highly Catalytic Phase with a Clearly Defined Path to Clinical Development of its Antiviral Pipeline | DCOY Stock News

Decoy Therapeutics 通过加速执行积累势头，进入一个高度催化的阶段，并且其抗病毒产品线的临床开发路径已经明确 | DCOY 股票新闻